Sponsors of a measure with the goal of legalizing cannabis in North Dakota did not receive a sufficient amount of signatures by the July 11th deadline to make it onto the ballot on November 8th, a sponsor said. The speakers needed to collect at least 13,452 signatures to the secretary of state’s office.

“Sounds like we just missed the mark. We had about 80 percent of the signatures we needed but weren’t able to get them all,” Tony Mangnall of Fargo, a member of the sponsoring committee and chairman of the North Dakota Libertarian Party, which endorsed the proposed initiative, stated.

Committee chairman Eric Olson of Fargo was not able to provide a comment. The proposed bill would have made it legal for anyone aged 21 or older to cultivate, have, use, and distribute cannabis without a license. Cannabis and cannabis paraphernalia would not have been able to be taxed by more than twenty percent. Mangnall stated that sponsors are going to collect signatures again another time to make it onto the ballot in 2018. They state that the reason they weren’t able to gather enough signatures is that they needed to resubmit the measure after their initial one’s language had errors, taking months off of their timeframe.

“Probably next time around we’ll have all the signatures we need,” Mangnall added.

At the same time, sponsors of a proposed bill to legalize medical cannabis planned to give the signatures to Secretary of State Al Jaeger at two p.m. Monday, July 11. They announced last week that they had approximately 15,500 signatures. Those signatures need to be checked for legitimacy, but if the right amount of signatures passed, the Compassionate Care Act would allow for the possession of up to three ounces of medical cannabis for treatment of more than twelve debilitating medical conditions. Here are examples of just a few: cancer, epilepsy, AIDS, and glaucoma.


MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

$VIN Appoint Scientific Advisory Board Chair to Pursue Clinical Testing of Cannabinoids

Vinergy Resources/MJ Biopharma Appoint Scientific Advisory Board Chair to Pursue Clinical Testing…